Aug 5, 2026 06:50AM
May 13, 2026 06:50AM
Jan 5, 2026 06:50AM
Nov 13, 2025 06:50AM
Aug 14, 2025 06:50AM
Aug 7, 2025 12:53PM
Jun 30, 2025 06:50AM Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
May 14, 2025 06:50AM
May 5, 2025 06:50AM
Mar 24, 2025 06:50AM
Mar 17, 2025 06:50AM
Mar 10, 2025 06:50AM
Feb 4, 2025 06:50AM
Dec 23, 2024 06:50AM Protalix BioTherapeutics Issues 2025 Letter to Stockholders
Nov 14, 2024 06:50AM
Nov 7, 2024 06:50AM
Oct 25, 2024 07:18AM
Sep 4, 2024 06:50AM
Sep 3, 2024 06:50AM
Aug 14, 2024 06:50AM
Aug 7, 2024 06:50AM Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024
May 29, 2024 08:38AM
May 10, 2024 06:50AM
May 3, 2024 06:50AM
Mar 14, 2024 06:50AM
Mar 7, 2024 06:50AM
Feb 23, 2024 06:50AM
Dec 26, 2023 06:50AM Protalix BioTherapeutics Issues 2024 Letter to Stockholders
Nov 6, 2023 06:50AM
Oct 30, 2023 06:50AM
Oct 9, 2023 06:50AM
Sep 6, 2023 06:50AM
Aug 7, 2023 06:50AM
Jul 31, 2023 06:50AM
May 30, 2023 06:50AM Protalix BioTherapeutics Issues Letter to Stockholders
May 4, 2023 06:50AM
Apr 27, 2023 06:50AM
Mar 21, 2023 06:50AM
Mar 13, 2023 06:53AM
Mar 13, 2023 06:50AM
Feb 27, 2023 06:30AM
Jan 3, 2023 06:50AM Protalix BioTherapeutics Issues 2023 Letter to Stockholders
Dec 21, 2022 04:30PM
Dec 5, 2022 06:53AM
Dec 5, 2022 06:50AM
Nov 14, 2022 06:30AM
Nov 7, 2022 06:50AM
Sep 6, 2022 06:50AM
Aug 15, 2022 06:50AM Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
Aug 8, 2022 06:50AM

330,175 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All